· Published by Health Canada · Official notice
This is duplicated text of a letter from Healthmark.
Contact the company for a copy of any references, attachments or enclosures.
Notice about Health Canada advisories
September 4, 2010
Subject: Excelsior Disposable SYRINGE W/Normal Saline (0.9% Sodium Chloride) Recall
Dear Customer,
Healthmark, in consultation with Health Canada, would like to inform you of important safety information regarding Excelsior Disposable saline SYRINGE manufactured by Excelsior Medical Corporation and distributed by Healthmark.
During a routine test of syringe integrity, Excelsior Medical discovered a possible integrity failure in their S5 product. Additional testing at Excelsior Medical has confirmed this finding and it is believed that there may be a dimensional issue with the 6 mL syringe product (product code S-5). Based on these tests, Excelsior Medical has taken a precautionary measure of recalling all syringe products of this size.
Managing marketed health product-related adverse incidents depends on health care professionals and consumers reporting them. Reporting rates determined on the basis of spontaneously reported post-market adverse incidents are generally presumed to underestimate the risks associated with health product treatments. Any cases of high fever following the use of the S-5 syringes or other serious or unexpected adverse incidents for medical devices in patients using Excelsior S-5 syringes should be reported to Healthmark or Health Canada at the following addresses:
Healthmark
8815, Henri Bourassa West,
Montréal Québec, Canada, H4S 1P7
Telephone: 514-336-0012
Fax: 514-336-7111
Toll Free: 1-800-665-5492
Any suspected adverse incident can also be reported to:
Health Products and Food Branch Inspectorate
HEALTH CANADA
Address Locator: 2003D
Ottawa, Ontario K1A 0K9
Telephone: The Inspectorate Hotline 1-800-267-9675
The Medical Devices Problem Report Form and Guidelines can be found on the Health Canada Web site.
For other medical device inquiries related to this communication, please contact Health Canada at:
Marketed Health Products Directorate
E-mail: mhpd_dpsc@hc-sc.gc.ca
Telephone: 613-954-6522
Fax: 613-952-7738
We appreciate your attention in resolving this matter and apologize for the inconvenience this causes.
Sincerely,
original signed by
William D. Fletcher
President